跳至主要内容
临床试验/NCT04482374
NCT04482374招募中不适用

Effects of Puberty and Pubertal Suppression on Insulin Sensitivity, Metabolic Rate and Vascular Health

University of Colorado, Denver1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年8月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Change in insulin sensitivity

研究概览

简要总结

This observational study will evaluate the effect of puberty suppression on insulin sensitivity, metabolic rate and vascular health among transgender female youth at baseline and 6 months after initiation of a gondoatropin releasing hormone agonist compared to matched cisgender male controls.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
9 Years 至 14 Years(Child)
性别
Male
接受健康志愿者

入选标准

  • Identify as a transgender female or cisgender male
  • Age 9-14 years at the time of enrollment
  • Tanner Stage 2-3 baseline pubertal development
  • Plan to start gonadotropin releasing hormone analogue clinically in < 2 months (for transgender females only)

排除标准

  • Cognitive, psychiatric, or physical impairment resulting in inability to tolerate the study procedures
  • Type 1 or 2 diabetes (by medical history)
  • On any medications that affect insulin sensitivity (e.g. metformin, antipsychotics)
  • Hypertension (resting BP ≥ 140/90 mm/Hg)
  • Weight > 400 lbs
  • On estrogen- or progesterone-containing medications at baseline
  • >3 hours of moderate-to-vigorous physical activity on the 3DPAR at the screening visit

结局指标

主要结局

Change in insulin sensitivity

时间窗: Baseline, 6 months

Insulin sensitivity assessed by the oral minimal model

次要结局

  • Change in body composition (fat mass, fat-free mass)(Baseline, 6 months)
  • Change in resting metabolic rate(Baseline, 6 months)
  • Change in large elastic artery stiffness(Baseline, 6 months)
  • Change in endothelial function(Baseline, 6 months)
  • Change in cerebrovascular function(Baseline, 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Puberty Suppression and Cardiometabolic Health | 临床试验